Holen Sie sich die Stockscreener-App
6.285
5.84%
0.355
Optimizerx Corp Aktie (OPRX) Neueste Nachrichten
Should you sell your OptimizeRx stock? - Cantech Letter
OptimizeRx Corporation (NASDAQ:OPRX) Q4 2025 Earnings Call Transcript - Insider Monkey
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
OptimizeRx (NASDAQ:OPRX) Price Target Cut to $20.00 by Analysts at Lake Street Capital - MarketBeat
OptimizeRx (NASDAQ:OPRX) Price Target Cut to $18.00 by Analysts at Roth Mkm - MarketBeat
OptimizeRx Warns Of Volatility From 'Most Favored Nation' Pricing Uncertainty - Bitget
Assessing OptimizeRx: Insights From 4 Financial Analysts - Benzinga
B. Riley Financial Reaffirms Buy Rating for OptimizeRx (NASDAQ:OPRX) - MarketBeat
OptimizeRx (OPRX) Target Price Lowered by Stephens & Co. | OPRX Stock News - GuruFocus
Stephens Cuts OptimizeRx (NASDAQ:OPRX) Price Target to $10.00 - MarketBeat
OptimizeRx (NASDAQ:OPRX) Announces Quarterly Earnings Results - MarketBeat
Stephens cuts OptimizeRx stock price target on soft pharma budgets - Investing.com Nigeria
OptimizeRx Corporation Q4 2025 Earnings Call Summary - Yahoo Finance
OptimizeRx (OPRX) Q4 2025 Earnings Call Transcript - AOL.com
Stifel cuts OptimizeRx stock price target on pharma spend slowdown - Investing.com
Stephens cuts OptimizeRx stock price target on soft pharma budgets By Investing.com - Investing.com South Africa
UPDATE – OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results - The Globe and Mail
OptimizeRx Corp (OPRX) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
OptimizeRx Q4 Earnings Call Highlights - MarketBeat
Stock Repurchase Plan Initiated by OptimizeRx (NASDAQ:OPRX) Board of Directors - MarketBeat
From loss to profit: OptimizeRx posts record $109.4M sales and $10M buyback - Stock Titan
Earnings call transcript: OptimizeRx Q4 2025 earnings beat expectations amid cautious market - Investing.com
OptimizeRx Corp. (OPRX) Q4 Earnings and Revenues Beat Estimates - Yahoo Finance
OPTIMIZERx earnings beat by $0.29, revenue topped estimates - Investing.com Canada
UPDATEOptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results - The Manila Times
Optimizerx Corp enters amendment no. 4 to financing agreementSEC filing - marketscreener.com
OptimizeRx Reports Strong Q4 2025 Results with Record Net Income and Adjusted EBITDA, Updates 2026 Revenue Guidance and Announces Share Repurchase Program - Quiver Quantitative
Optimizerx Corp Enters Amendment No. 4 To Financing Agreement- SEC Filing - TradingView
OptimizeRx Q4 Adjusted Earnings Rise; Reports Buyback Program - marketscreener.com
Geopolitics Watch: Can OptimizeRx Corporation sustain earnings growthTrade Performance Summary & Smart Money Movement Tracker - baoquankhu1.vn
OptimizeRx Authorizes $10 Million Share Repurchase Program - TipRanks
OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results - The Manila Times
OptimizeRx (Nasdaq: OPRX) returns to profit and unveils $10M share repurchase plan - Stock Titan
OptimizeRx Sets Fourth Quarter and Full Year 2025 Financial Results Conference Call for March 5, 2026, at 4:30 P.m. ET - 富途牛牛
Earnings To Watch: OptimizeRx Corp (OPRX) Reports Q4 2025 Result - GuruFocus
OptimizeRx Corp. (NASDAQ:OPRX) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
OptimizeRx Corp expected to post earnings of 23 cents a shareEarnings Preview - TradingView
OPRX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Portfolio Update: Can OptimizeRx Corporation weather a recessionMarket Volume Summary & Pattern Based Trade Signal System - baoquankhu1.vn
OptimizeRx (OPRX) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Can OptimizeRx Corporation sustain earnings growthQuarterly Trade Review & Breakout Confirmation Alerts - mfd.ru
Is OptimizeRx Corporation stock trending bullishPortfolio Return Summary & Step-by-Step Trade Execution Guides - mfd.ru
CenterBook Partners LP Invests $6.33 Million in OptimizeRx Corp. $OPRX - MarketBeat
OptimizeRx (OPRX): Small-Cap AI Health Stock Quietly Repricing Higher - AD HOC NEWS
US Market Recap: Can OptimizeRx Corporation maintain sales growthEarnings Beat & Long-Term Growth Plans - baoquankhu1.vn
Autoship and Rx: The Backbone for Hitting Chewy's Margin Target - AOL.com
Brokerages Set OptimizeRx Corp. (NASDAQ:OPRX) Price Target at $21.00 - Defense World
OptimizeRx Corp. (NASDAQ:OPRX) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Portfolio Update: Can OptimizeRx Corporation sustain earnings growth2025 Price Targets & Daily Volume Surge Trade Alerts - baoquankhu1.vn
OptimizeRx Sets Fourth Quarter and Full Year 2025 Financial Results Conference Call for March 5, 2026, at 4:30 p.m. ET - The Manila Times
OptimizeRx Sets Fourth Quarter and Full Year 2025 Financial - GlobeNewswire
Strength Seen in OptimizeRx (OPRX): Can Its 7.5% Jump Turn into More Strength? - Yahoo Finance
OptimizeRx (NASDAQ:OPRX) Stock Price Down 6.1%Here's What Happened - MarketBeat
Day Trade: Can OptimizeRx Corporation ride the EV waveJuly 2025 Review & Expert Verified Stock Movement Alerts - baoquankhu1.vn
How Evolving Valuation Assumptions Are Rewriting The Story For OptimizeRx (OPRX) - Yahoo Finance
Market Outlook: Will OptimizeRx Corporation benefit from sector rotation2025 Risk Factors & AI Powered Trade Plan Recommendations - baoquankhu1.vn
OptimizeRx Corp. (NASDAQ:OPRX) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
OptimizeRx Corp. (NASDAQ:OPRX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Is OptimizeRx Corporation stock attractive after correctionSell Signal & Daily Profit Maximizing Trade Tips - Улправда
1.64%
0.37%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):